Los Angeles Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

$29.2 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$26.2 - $36.08 $75,141 - $103,477	-2,868 Reduced 19.12%	12,132 $325,000
Q2 2023 Aug 03, 2023	BUY	$25.16 - $41.38 $163,288 - $268,556	6,490 Added 76.26%	15,000 $534,000
Q1 2023 May 04, 2023	SELL	$23.68 - $38.51 $106,536 - $173,256	-4,499 Reduced 34.58%	8,510 $216,000
Q4 2022 Feb 06, 2023	SELL	$28.0 - $40.56 $30,800 - $44,616	-1,100 Reduced 7.8%	13,009 $527,000
Q3 2022 Nov 02, 2022	BUY	$29.63 - $48.31 $41,511 - $67,682	1,401 Added 11.02%	14,109 $466,000

Q2 2022 Aug 05, 2022	BUY	$27.79 - $50.61 $107,297 - $195,405	3,861 Added 43.64%	12,708 $447,000
Q1 2022 May 06, 2022	BUY	$39.62 - $69.97 $15,610 - $27,568	394 Added 4.66%	8,847 $407,000
Q4 2021 Feb 03, 2022	BUY	$58.09 - $82.51 $7,551 - $10,726	130 Added 1.56%	8,453 $560,000
Q3 2021 Nov 08, 2021	SELL	$58.38 - $84.96 $45,594 - $66,353	-781 Reduced 8.58%	8,323 $520,000
Q2 2021 Aug 05, 2021	SELL	$62.15 - $90.32 $722,618 - $1.05 Million	-11,627 Reduced 56.09%	9,104 $754,000
Q1 2021 May 05, 2021	SELL	$61.35 - $90.47 $1.21 Million - $1.78 Million	-19,725 Reduced 48.76%	20,731 $1.37 Million
Q4 2020 Feb 04, 2021	SELL	$43.82 - $85.37 $206,392 - $402,092	-4,710 Reduced 10.43%	40,456 $3.1 Million
Q3 2020 Nov 02, 2020	SELL	$33.21 - $51.27 $2.25 Million - $3.48 Million	-67,827 Reduced 60.03%	45,166 $1.95 Million
Q2 2020 Aug 05, 2020	BUY	$26.12 - $43.27 $34,556 - $57,246	1,323 Added 1.18%	112,993 $4.88 Million
Q1 2020 May 04, 2020	BUY	$20.56 - $63.12 $170,648 - $523,896	8,300 Added 8.03%	111,670 $3.21 Million
Q4 2019 Feb 07, 2020	BUY	$28.14 - $73.01 $114,389 - $296,785	4,065 Added 4.09%	103,370 $6.56 Million
Q3 2019 Nov 07, 2019	BUY	$26.26 - $34.86 $2.05 Million - $2.73 Million	78,225 Added 371.09%	99,305 $2.8 Million
Q2 2019 Jul 29, 2019	BUY	$17.43 - $28.82 $88,893 - $146,982	5,100 Added 31.91%	21,080 $559,000
Q1 2019 Apr 25, 2019	BUY	$12.05 - $20.18 $192,559 - $322,476	15,980 New	15,980 $293,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account